HSA · registration DE0510643

BD CD4 (SK3) PerCP-Cy5.5

Name: BD CD4 (SK3) PerCP-Cy5.5 — HSA DE0510643
Creator: Becton, Dickinson and Company, BD Biosciences
Keywords: BD CD4 (SK3) PerCP-Cy5.5, BD CD4 (SK3) PerCP-Cy5.5, DE0510643, Clinical chemistry, HSA

SingaporeClinical chemistryClass CBecton, Dickinson and Company, BD Biosciences

Verified

Official record identity

Registration number: DE0510643
Model name: BD CD4 (SK3) PerCP-Cy5.5
Model identifier: 332772
Registration date: April 28, 2025

Classification

Risk class: Class C
Published category: Clinical chemistry

Published parties

Product owner: Becton, Dickinson and Company, BD Biosciences
Registrant / registration holder: BECTON DICKINSON HOLDINGS PTE. LTD.

Official description

CD4 (SK3) is intended for in vitro diagnostic use in the identification of cells expressing the CD4 antigen in peripheral blood, using a BD FACSLyric™ flow cytometer.

Additional source fields

Product owner address: 155 North McCarthy Boulevard, Milpitas, California, 95035, United States
Registrant address: 10 COLLYER QUAY, #10-01, OCEAN FINANCIAL CENTRE, Singapore 049315

About this record

This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.